NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News $165.45 +7.29 (+4.61%) As of 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABU alerts:Sign Up Key Stats Today's Range$155.90▼$166.0350-Day Range$135.79▼$210.8252-Week Range$53.14▼$212.45Volume581,436 shsAverage Volume624,030 shsMarket Capitalization$466.57 millionAssets Under Management$437.97 millionDividend Yield0.74%Net Expense Ratio0.93%Aggregate RatingModerate Buy ETF Overview The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.57%0.51%0.53%Other Expenses0.18%0.47%0.55%0.58%0.55%Total Expense0.93%0.74%0.76%0.74%0.73%Fee Waiver0.00%-0.71%-0.64%-0.70%-0.62%Net Expense0.93%0.59%0.63%0.58%0.60% Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABU ETF News HeadlinesLABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited BreakoutApril 27, 2026 | 247wallst.comEqual-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position NowApril 23, 2026 | 247wallst.comThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.June 3 at 1:00 AM | American Alternative (Ad)SPXL: Replacing SPY With 3x Leverage Proven To Yield Positive Long-Term ResultsMarch 25, 2026 | seekingalpha.comTriple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026January 16, 2026 | 247wallst.comDirexion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.9097December 23, 2025 | msn.comSee More Headlines LABU ETF - Frequently Asked Questions How have LABU shares performed this year? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $159.39 at the start of the year. Since then, LABU stock has increased by 3.8% and is now trading at $165.45. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Direxion Daily S&P Biotech Bull 3x Shares shares reverse split before market open on Monday, December 4th 2023.The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Direxion Daily S&P Biotech Bull 3x Shares' top institutional investors include IMC Chicago LLC (0.06%) and Halbert Hargrove Global Advisors LLC (0.04%). How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings176 Fund Statistics Assets Under Management$437.97 million Average Daily Volume$579.40 thousand Discount/Premium0.31% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume5,413 Put Options3,613 Call Options1,800 Short Interest504,200 shs Miscellaneous Outstanding Shares2,820,000Beta2.50 Creation Unit50,000 Creation Fee$250.00 Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Top 10 LABU HoldingsDreyfus Govt Cash Man InsHolding Weight: 16.85%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 4.70%Goldman Finl Sq Trsry Inst 506Holding Weight: 4.34%S&P Biotechnology Select Industry Index SwapHolding Weight: 4.17%S&P Biotechnology Select Industry Index SwapHolding Weight: 2.46%S&P Biotechnology Select Industry Index SwapHolding Weight: 2.05%S&P Biotechnology Select Industry Index SwapHolding Weight: 1.60%Revolution Medicines (NASDAQ:RVMD)Holding Weight: 1.30%Travere Therapeutics (NASDAQ:TVTX)Holding Weight: 1.28%TG Therapeutics (NASDAQ:TGTX)Holding Weight: 1.18%Full Holdings DetailsLABU Sector ExposureLABU Industry Exposure This page (NYSEARCA:LABU) was last updated on 6/3/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
